bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.500
+0.050 (3.45%)
Nov 28, 2025, 4:00 PM EST - Market closed
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $6.74 million as of November 28, 2025. Its market cap has decreased by -67.27% in one year.
Market Cap
6.74M
Enterprise Value
-474.99K
1-Year Change
-67.27%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $6.74M, a decrease of -85.04%. That is a compound annual growth rate of -44.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 6.51M | -54.07% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
| Sep 1, 2022 | 45.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |